[Treatment of bone involvement in Gaucher diseases with imiglucerase combined with miglustat].
作者信息
Marie Isabelle
机构信息
Département de Médecine Interne, CHU de Rouen - Bois-Guillaume, 76031 Rouen cedex, France.
出版信息
Presse Med. 2009 Dec;38 Suppl 2:2S68-70. doi: 10.1016/S0755-4982(09)73676-0.
Abstract
摘要
相似文献
1
[Treatment of bone involvement in Gaucher diseases with imiglucerase combined with miglustat].
Presse Med. 2009 Dec;38 Suppl 2:2S68-70. doi: 10.1016/S0755-4982(09)73676-0.
2
Combined miglustat and enzyme replacement therapy in two patients with type 1 Gaucher disease: two case reports.
J Med Case Rep. 2018 Jan 27;12(1):19. doi: 10.1186/s13256-017-1541-7.
3
[Osteoarticular manifestations of Gaucher disease in adults: pathophysiology and treatment].
Rev Med Interne. 2007 Oct;28 Suppl 2:S180-2. doi: 10.1016/s0248-8663(07)78878-1.
4
[Osteoarticular manifestations of Gaucher disease in adults: pathophysiology and treatment].
Presse Med. 2007 Dec;36(12 Pt 3):1971-84. doi: 10.1016/j.lpm.2007.04.012. Epub 2007 May 10.
5
Miglustat: new drug. In type 1 Gaucher's disease : a slight benefit after imiglucerase therapy.
Prescrire Int. 2005 Oct;14(79):168-70.
6
Gaucher disease: hematologic and oncologic implications.
Clin Adv Hematol Oncol. 2011 Oct;9(10):771-2.
7
Imino sugar therapy for type 1 Gaucher disease.
Glycobiology. 2000 Nov;10(11):iv-vi.
8
Patients with Gaucher type 1: Switching from imiglucerase to miglustat therapy.
Blood Cells Mol Dis. 2018 Feb;68:180-184. doi: 10.1016/j.bcmd.2017.01.007. Epub 2017 Jan 16.
9
Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement.
Blood. 2007 Oct 1;110(7):2296-301. doi: 10.1182/blood-2007-02-075960. Epub 2007 Jul 3.
10
Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case report.
J Med Case Rep. 2017 Jan 20;11(1):19. doi: 10.1186/s13256-016-1147-5.
Zotero 插件